Genenta Science(NASDAQ:GNTA) 
Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of gliobl...
Website: https://www.genenta.com
Founded: 2014
IPO Price: $11.5 (Dec 15, 2021)
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 3.80
H 3.80
L 3.60
C 3.60
V 2,332
10EMA 3.60
20EMA 3.60
60EMA 3.60
120EMA 3.60
250EMA 3.60